Daniel Rathkey

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression”.

Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.012

N/A

0.637DataRank · unranked

69 citations

Manakamana Khanal, Junko Murai, Jingli Zhang, Manjistha Sengupta, Qun Jiang +13 more

Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti–PD-1 antibody in patients with mesothelioma and mouse tumor models

Science Translational Medicine(2020)10.1126/scitranslmed.aaz7252

N/A

0.571DataRank · unranked

44 citations

Azam Ghafoor, Idrees Mian, Daniel Rathkey, Anish Thomas, Christine Alewine +8 more